Clinical Trials Browser

Completed × INDUSTRY × resiquimod × Clear all

Adenocarcinoma, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Esophageal Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Neoplasms, Plasma Cell

NCT00114920 2007-02-19

Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Phase 2 Completed

88 enrolled

Warts

NCT00115141 2007-02-19

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Phase 2 Completed

88 enrolled

Warts

NCT00116662 2007-02-19

An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Phase 2 Completed

84 enrolled

Warts

NCT00116675 2007-02-19

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Phase 2 Completed

84 enrolled

Warts

NCT00117923 2007-02-19

Study With a Topical Gel to Treat Common Warts in Adults

Phase 2 Completed

88 enrolled

Warts

Clinical Trials

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Study With a Topical Gel to Treat Common Warts in Adults